Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression

We investigated whether aspartate transaminase (AST)-to-alanine aminotransferase (ALT) ratio and its change during the course of treatment in castration-resistant prostate cancer (CRPC) patients is associated with tumor condition and lethality. Clinical data from 130 CRPC patients were retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsui, Yozo, Yamabe, Fumito, Hori, Shunsuke, Uetani, Masato, Aoki, Hiroshi, Sakurabayashi, Kei, Okawa, Mizuho, Kobayashi, Hideyuki, Nagao, Koichi, Nakajima, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504303/
https://www.ncbi.nlm.nih.gov/pubmed/37714917
http://dx.doi.org/10.1038/s41598-023-42711-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504303/
https://www.ncbi.nlm.nih.gov/pubmed/37714917
http://dx.doi.org/10.1038/s41598-023-42711-z

Ejemplares similares